ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 136037 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 136037; 2) Community: the network communities that were significantly associated with the response to NSC 136037; 3) Molecule: the relationships between components within communities and NSC 136037; 4) MDR: the compounds that were significantly associated with the NSC 136037.

NSC Compound Enrichment Correlation
NSC 671169 Null 0.00725424828633685 0.19786041
NSC 676916 1-[m-methyl anilino malonyl]-3-methyl-4-[4'-.beta.-sulphato ethyl sulphonyl phenyl azo]-5-pyrazolone 0.00725424828633685 0.28778821
NSC 682831 Butanimidoyl chloride, N-[[[(3-fluorophenyl)amino] carbonyl]oxy]- 0.00725424828633685 0.081764864
NSC 745455 Null 0.00725424828633685 0.18697085
NSC 761821 Null 0.00725424828633685 0.22058287
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.00995118568011489 0.15221456
NSC 135880 Null 0.0105244982742819 0.1960095
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0105244982742821 0.29226594
NSC 359239 Antibiotic X-14766A 0.0105244982742821 0.25826592
NSC 638409 (E)N-Ethyl-[3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoamide 0.0105244982742821 0.16803372
Total:48  Current:8    [First] [Prev] [Next] [Last]